文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
C. Tian
发表
A first-in-human phase I study of the PD-1 inhibitor, retifanlimab (INCMGA00012), in patients with advanced solid tumors (POD1UM-101)
U. Banerji, J. Powderly, N. Lakhani, 2024, ESMO open.